Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neumología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Double-blinded Extension Study to Evaluate the Long-term Safety and Tolerability of Itepekimab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Participated in Either EFC16750 or EFC16819 Clinical Studies
INTERVENTIONAL
Inicio: 11 de ene de 2024
ID: NCT06208306
Completado
Fase 3
ClinicalTrials.gov
An Open-Label Randomized Phase III Trial of BMS-936558 (Nivolumab) Versus Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)
INTERVENTIONAL
Inicio: 16 de oct de 2012
ID: NCT01642004
Completado
ClinicalTrials.gov
Doubling Outcomes by Lung Cancer Early Diagnosis: An Observational, Study to Collect Real-world Evidence (RWE) on the Management of Pulmonary Nodules Across Latin-America
OBSERVATIONAL
Inicio: 30 de dic de 2021
ID: NCT05091437
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Open-Label, Randomized Study of Atezolizumab (MPDL3280A, Anti-Pd-L1 Antibody) in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Patients Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer
INTERVENTIONAL
Inicio: 30 de abr de 2016
ID: NCT02657434
Completado
Fase 3
ClinicalTrials.gov
An International, Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Dapagliflozin in Respiratory Failure in Patients With COVID-19
INTERVENTIONAL
Inicio: 22 de abr de 2020
ID: NCT04350593
Reclutando
Fase 3
ClinicalTrials.gov
An Open Label Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD)
INTERVENTIONAL
Inicio: 12 de dic de 2024
ID: NCT06716606
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 12 Week Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety, and Tolerability of Rilzabrutinib in Participants With Moderate-to-severe Asthma Who Are Not Well Controlled on Inhaled Corticosteroid (ICS) Plus Long-acting β2 Adrenergic Agonist (LABA) Therapy
INTERVENTIONAL
Inicio: 12 de dic de 2021
ID: NCT05104892
Completado
Fase 3
ClinicalTrials.gov
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
INTERVENTIONAL
Inicio: 12 de mar de 2009
ID: NCT00863681
Completado
ClinicalTrials.gov
An Observational Study of the Safety of Atezolizumab in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer in Argentina
OBSERVATIONAL
Inicio: 27 de dic de 2017
ID: NCT03321695
Terminado
ClinicalTrials.gov
TREATMENT RESISTANCE FOLLOWING ANTI-CANCER THERAPIES (TRANSLATE)
INTERVENTIONAL
Inicio: 13 de feb de 2019
ID: NCT04436120
Aún no recluta
ClinicalTrials.gov
Development and Validation of an Obstetric Organ Dysfunction Score to Predict Mortality in Intensive Care Unit: A Multicenter, Prospective, Cohort Study
OBSERVATIONAL
Inicio: 1 de ago de 2025
ID: NCT07068022
Completado
Fase 2
ClinicalTrials.gov
A Phase II, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of MEDI3506 in Adult Participants With Uncontrolled Moderate-to-severe Asthma
INTERVENTIONAL
Inicio: 17 de sept de 2020
ID: NCT04570657
Completado
Fase 3
ClinicalTrials.gov
A 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
INTERVENTIONAL
Inicio: 1 de feb de 2011
ID: NCT01270464
Completado
Fase 3
ClinicalTrials.gov
An Open Label, Single Arm Study to Assess the Safety and Immunogenicity of Omalizumab Liquid Administered Subcutaneously to Male and Female Adolescents and Adults With Persistent Allergic Asthma
INTERVENTIONAL
Inicio: 1 de jul de 2007
ID: NCT00500539
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2 Randomized Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
INTERVENTIONAL
Inicio: 17 de feb de 2021
ID: NCT04623775
Completado
Fase 1
ClinicalTrials.gov
A Randomized, Double-blind Study of Treatment With a Known Anti-inflammatory (Prednisolone) to Evaluate Novel Endpoints in Patients With Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 21 de mar de 2006
ID: NCT00379730
Terminado
Fase 3
ClinicalTrials.gov
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
INTERVENTIONAL
Inicio: 4 de oct de 2016
ID: NCT02657356
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC 3781) Versus Oral Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia
INTERVENTIONAL
Inicio: 1 de ago de 2016
ID: NCT02813694
Completado
ClinicalTrials.gov
Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study
INTERVENTIONAL
Inicio: 14 de sept de 2016
ID: NCT02447692
Completado
ClinicalTrials.gov
Efficacy of BPS (Bacterial Pneumonia Score) Guided Antibiotic Use in Children With Community Acquired Pneumonia on Reducing Antibiotic Use as Compared to Standard Care Practice (Current Guidelines for CAP)
INTERVENTIONAL
Inicio: 1 de mar de 2010
ID: NCT01041209
Anterior
1
...
16
17
18
...
434
Siguiente
Filtros